← Leaderboards
Stephen Nash
Ohio State University
$103,353
Attributed
$103,353
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $40K · FY2005–08$50K$37.5K$25K$12.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$103,353 · 3
By mechanism
M01$103,353 · 3
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Jerry Mendell$11,877,761
- Janice K Kiecolt-Glaser$29,757,164
- William David Arnold$3,667,318
- Zihai Li$25,199,729
- Michael X Zhu$12,758,816
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsAmyotrophic Lateral SclerosisUnited States National Institutes Of HealthComputer Retrieval Of Information On Scientific Projects DatabaseFundingGrantInstitutionInsulin-Like Growth Factor IResearch PersonnelResourcesSourceAffectInsulinlike Growth FactorTracheostomy ProcedureLateralManualsMuscleMuscle WeaknessClinical ResearchPerformanceDrug Screening /EvaluationProtocols DocumentationRateHormone Therapy
Grant awards (5)
CLINICAL TRIAL: CLINICAL TRIAL OF IGF-1 IN PATIENTS WITH AMYOTROPHIC LATERAL SCL$2,079
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL OF IGF-1 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)$17,875
M01 · FY2007 · RR · contact PI
CLINICAL TRIAL OF IGF-1 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)$40,048
M01 · FY2006 · RR · contact PI
CLINICAL TRIAL OF IGF-1 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)$38,517
M01 · FY2005 · RR
Clinical Trial of IGF-1 in Patients with ALS$4,834
M01 · FY2004 · RR